Prospective Registry of Acute Coronary Syndromes in Ferrara
ConditionAcute Coronary Syndromes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital of Ferrara
About this trial
The ARYOSTO has been designed to describe the clinical epidemiology and the current management of acute coronary syndromes (ACS) in the area of Ferrara. Especially, the Authors will evaluate the medical and interventional management of ACS patients admitted to hospitals in the area of Ferrara and receiving coronary artery angiography and percutaneous coronary intervention (PCI) in the hub center of Ferrara (Azienda Ospedaliera Universitaria di Ferrara, Cona (FE), Italy)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age >18 years
hospital admission for acute coronary syndromes
resident in the Ferrara area
Disqualifiers
none
Trial population
patients admitted to hospital with diagnosis of acute coronary syndromes according current European guidelines
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
prospective collection of data and follow-up
Other interventionprospective collection of data and follow-up of all patients admitted to hospital for ACS
Treatment groups
10,000 Participants
are divided into 1 treatment groupGroup A: ACS patients1 intervention
Trial outcomes
Primary outcomes
1
1-year combined primary endpoint
1-year occurence of cardiac death, myocardial infarction, cerebrovascular accident
Time frame
1 yearSecondary outcomes
1
2-year combined endpoint
2-year occurence of cardiac death, myocardial infarction, cerebrovascular accident
Time frame
2 years2
3-year combined endpoint
3-year occurence of cardiac death, myocardial infarction, cerebrovascular accident
Time frame
3 years3
5-year combined endpoint
5-year occurence of cardiac death, myocardial infarction, cerebrovascular accident
Time frame
5 years4
annual occurrence of single components of primary endpoint
occurrence of each component of the primary endpoint
Time frame
1, 2, 3, 4, 5 yearsOther outcomes
1
emergency room admittance
assessment of number of admission to emergency room for any causes
Time frame
1, 2, 3, 4, 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov